YS Biopharma Announces Results of Extraordinary General Meeting held on February 22, 2024
/PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing,...